BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
64 results:

  • 1. Genomic profiling of primary and metastatic thyroid cancers.
    Máximo V; Melo M; Zhu Y; Gazzo A; Sobrinho Simões M; Da Cruz Paula A; Soares P
    Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 38015791
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Pheochromocytoma associated with primary hyperparathyroidism and type 1 neurofibromatosis].
    Ryabchenko EV; Dremlyuga NV; Mezhinskaya EM; Polyansky EA
    Khirurgiia (Mosk); 2023; (7):120-127. PubMed ID: 37379415
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Genetics of Diffuse Sclerosing Papillary thyroid cancer.
    Alswailem M; Alghamdi B; Alotaibi A; Aljomiah A; Al-Hindi H; Murugan AK; Abouelhoda M; Shi Y; Alzahrani AS
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e704-e711. PubMed ID: 36995892
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MULTIPLE NEUROENDOCRINE NEOPLASIA IN A PATIENT WITH TYPE I NEUROFIBROMATOSIS (nf1): REPORT OF A NEW MUTATION (nf1, EXONS 2-30 DELETION) AND LITERATURE REVIEW.
    Kanno DT; Mattos RLM; Campos FG; Siqueira RM; Carvalho RB; Real Martinez CA
    Arq Bras Cir Dig; 2023; 35():e1702. PubMed ID: 36629684
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.
    Chen S; Guan L; Zhao X; Yang J; Chen L; Guo M; Zhao J; Chen C; Zhou Y; Han Y; Xu L
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):915-930. PubMed ID: 36379611
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
    Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
    Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic thyroid Carcinoma.
    Wang JR; Montierth M; Xu L; Goswami M; Zhao X; Cote G; Wang W; Iyer P; Dadu R; Busaidy NL; Lai SY; Gross ND; Ferrarotto R; Lu C; Gunn GB; Williams MD; Routbort M; Zafereo ME; Cabanillas ME
    JCO Precis Oncol; 2022 Aug; 6():e2100504. PubMed ID: 35977347
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of fusions with potential clinical significance in melanoma.
    Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
    Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach.
    Buddham R; Chauhan S; Narad P; Mathur P
    J Microbiol Biotechnol; 2022 Mar; 32(3):365-377. PubMed ID: 35001007
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Endocrine and neuroendocrine tumors].
    Riss P; Scheuba K; Strobel O
    Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.
    Chevalier B; Dupuis H; Jannin A; Lemaitre M; Do Cao C; Cardot-Bauters C; Espiard S; Vantyghem MC
    Front Endocrinol (Lausanne); 2021; 12():678869. PubMed ID: 34025587
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Human Papilloma Virus 18-Positive Submucosal Small Cell Neuroendocrine Carcinoma of the Vagina: An Immunohistochemical and Genomic Study.
    Kitazono I; Akahane T; Sakihama M; Yanazume S; Matsushita M; Tabata K; Kobayashi Y; Kobayashi H; Umekita Y; Tanimoto A
    Int J Surg Pathol; 2021 Dec; 29(8):870-876. PubMed ID: 33792412
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. thyroid sclerosing mucoepidermoid carcinoma with eosinophilia in conjunction with parotid basal cell adenoma: Cytologic, histologic, and molecular features.
    Noor M; Russell DK; Israel AK; Lott Limbach A
    Diagn Cytopathol; 2021 Jul; 49(7):E262-E268. PubMed ID: 33484239
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case Report and Literature Review.
    Arif AA; Kim PTW; Melck A; Churg A; Schwartz Z; Stuart HC
    Am J Case Rep; 2021 Jan; 22():e927761. PubMed ID: 33452231
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Limitations and benefits of FDG-PET/CT in nf1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
    Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
    Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
    Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metabolic and hormonal side effects of mitotane treatment for adrenocortical carcinoma: A retrospective study in 50 Danish patients.
    Vikner ME; Krogh J; Daugaard G; Andreassen M
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):141-149. PubMed ID: 32996176
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary thyroid Carcinoma with Both
    Demir Gündoğan B; Sağcan F; Tuğ Bozdoğan S; Balcı Y; Tuncel Daloğlu F; Çağlar Çıtak E
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):342-346. PubMed ID: 32702947
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.